Summary Reduced expression of the putative metastasis-suppressor gene, nm23-1, has previously been correlated with high tumour metastatic potential. The involvement of the related and proximally-located nm23-2 gene in the suppression of tumour metastasis, however, has not yet been tested. In this study, we compared nm23-2 RNA levels in cell lines derived from three independent rat mammary carcinomas. Northern blot analysis revealed no correlation between nm23-2 RNA levels and metastatic potential in parent or clonal cell lines derived from chemically-induced (MAT 13762, DMBA-8) or spontaneous (BCI) rat mammary carcinomas. Cloning and sequencing of an nm23-2 cDNA from metastatic BCI cells demonstrated that the predicted coding sequence of nm23-2 RNA in these cells was not inactivated by mutation. Further analysis showed that the nm23-2 gene was not down-regulated in H-ras-transfected metastatic clones or other metastatic cell lines derived from a spontaneous rat paraoral squamous cell carcinoma, BIO. The data do not suggest a correlation between nm23-2 gene expression and metastasis-suppression in these tumours.
Cancer metastasis is a complex process in which tumour cells of a primary neoplasm invade normal tissue, enter and escape the vasculature, and generate secondary tumours or metastases (reviewed in Fidler, 1990) . The metastatic process comprises sequential steps, each of which is likely to entail the activation and/or repression of specific genes or gene products, depending on the origin and type of tumour (Hart et al., 1989; Fidler & Radinsky, 1990) . nm23-1 is one such gene reported to be down-regulated in metastatic cells of different rodent tumours (Steeg et al., 1988a,b) . The human homologue of this gene, nm23-H1, encodes one sub-unit of the enzyme NDP kinase (Gillies et al., 1991) . The mouse nm23-1 gene was demonstrated to reduce experimental metastasis following transfection into mouse melanoma cells (Leone et al., 1991) , and subsequently was proposed to represent a putative 'metastasis-suppressor' gene (reviewed in Liotta et al., 1991) . Recent evidence indicates that the structurally-related human nm23-H2 gene (Stahl et al., 1991) , encoding a second sub-unit of NDP kinase (Gillies et al., 1991) , co-localises with nm23-H1 to 17q21.3, a human chromosomal region known to contain the locus for earlyonset familial breast-ovarian cancer and other genes involved in tumourigenesis (Backer et al., 1993) . The rat nm23-1 (NDP kinase ,B) and nm23-2 (NDP kinase a) genes also co-localise to within 3 kbp in rat genomic DNA (Shimada et al., 1993) . While the nm23-1 genes have remained the focus of intense investigation, comparatively little is known of nm23-2 gene expression, despite the earlier proposal that the human nm23-H2 gene also represented a metastasis suppressor (Stahl et al., 1991) . This study was therefore undertaken to test the hypothesis that nm23-2 represents a metastasissuppressor gene. Rat nm23-2 cDNA was cloned and nm23-2 specific RNA levels were compared in cell lines derived from independent rat mammary and oral carcinomas. Expression of the rat nm23-2 gene did not strictly correlate with metastatic potential in the tumour cells studied.
Materials and methods
Cell lines and culture The tumour-forming ability and experimental and/or spontaneous metastatic potential of each cell line used in this study was previously determined, either directly in this laboratory or through kind collaboration with Dr J.R. Gibbins (Department of Pathology, University of Sydney). Cytoplasmic RNA was prepared from cells at the same time metastatic ability was assessed, and subsequently was utilised in the Northern blots of this study. A brief description of the cell lines is necessary to place the results from this study into perspective.
Rat mammary carcinoma cell lines The derivation and characteristics of cell lines derived from the chemically-induced rat mammary adenocarcinomas DMBA-8 and MAT 13762, have previously been described in some detail (Ramshaw & Badenoch-Jones, 1985; Ramshaw et al., 1986) . The original parent cell line adapted from the DMBA-8 tumour , is capable of forming tumours but does not metastasise in syngeneic Fischer 344 rats (Ramshaw & Badenoch-Jones, 1985) . A minimal in vivo selection of DMBA-8-derived clones, resulted in cell lines which were completely non-metastatic (NM4) or highly metastatic (metastatic ascites, MA; metastatic clone 2, MC2) when injected sub-cutaneously or via tail vein into host animals (originally described in Ramshaw & Badenoch-Jones, 1985; Ramshaw et al., 1986; Dear et al., 1989) . The MAT 13762 parent cell line, by contrast, was itself highly metastatic in syngeneic Fischer 344 rats (originally described in Ramshaw & Badenoch-Jones, 1985) . A MAT 13762 6-thioguanine-resistant variant (J-clone), however, maintained some tumour-forming potential but was found to be consistently incapable of metastasising in syngeneic host rats (Ramshaw et al., 1982) . The experimental metastatic potential of each of these cell lines was reassessed and re-confirmed recently in syngeneic rats (Henderson et al., 1992) al., 1991). al., 1991) . Co-transfection of A5P/B10 cells with plasmid pEJ2 containing the Ha-ras oncogene, and pSV2neo DNA, permitted the selection of cell lines which aquired metastatic ability (K23, K28 and K29), as described in Gibbins et al. (1991) . Of these, K29 was the most aggressive tumourforming cell line. The anaplastic T952/F7 cell line was cloned from a lymph node metastasis in an animal inoculated with A5P/B10 cells co-transfected with pSV2neo plus BCI cell genomic DNA (Gibbins et al., 1991) . The non-metastatic Y43BP cell line was obtained from a benign tumour produced by the inoculation of ASP/B10 cells co-transfected with pSV2neo and normal lymphocyte DNA (Gibbins et al., 1991) . Somatic cell hybridisation in this laboratory of these two cell lines and selection from a primary footpad tumour resulted in generation of a highly metastatic cell line, F4TQ2AF (described in Paine et al., 1992) . Cytoplasmic RNA was prepared from the cell lines described above (in addition to primary rat embryo fibroblasts; REF) at the time metastatic potential was assessed (tumour cells were inoculated into footpads of syngeneic animals and lymph node metastasis scored), the data of which is described in Gibbins et al. (1991) and Paine et al. (1992) . Cells and/or cytoplasmic RNA at that time were generously supplied by Dr J.R. Gibbins and Dr M. Paine. All cell lines used in this study were determined to be mycooplasma negative.
cDNA cloning and sequencing The human nm23-H2 gene encodes a protein identical to human NDP kinase B (Stahl et al., 1991; Gillies et al., 1991) , which in rat cells corresponds to a protein named rat NDP kinase a (Kimura et al., 1990) . Rat nm23-2 (or NDP kinase a) cDNA was cloned from a cDNA library synthesised from metastatic BC1 rat mammary carcinoma cells (see Paine et al., 1992) , by screening with a 21 base 32P-labelled oligonucleotide (nm23b; 5'AGATGGTCCATCCATCCAGT-CAGTG-3') selected from the published rat NDP kinase oc gene 3' untranslated region (Kimura et al., 1990 ) and using standard techniques (Sambrook et al., 1989) . DNA from positive clones were purified and further screened by polymerase chain reaction (PCR) using the forward primer nm23a (5'-GCTTCTGCAGGACCATGGCC-3') which overlaps the translation start site (Kimura et al., 1990) , and nm23b as reverse primer. A full-length (-600 bp) PCR product was cloned and sequenced using standard techniques (Sambrook et al., 1989) . Cloning and sequencing of rat nm23-2 cDNA from a highly metastatic cell line ensured that the mRNA detected by Northern blot analysis in these cells was not structurally altered, but was likely to encode a functional NDP kinase a peptide (Kimura et al., 1990) . Results nm23-2 RNA levels in cell lines derivedfrom rat mammary carcinomas The non-metastatic DMBA-8 parent cell line, and nonmetastatic (NM4) or highly metastatic (MA, MC2) clonal derivatives were tested for nm23-2 RNA expression by Northern blot analysis (Figure la) . Interestingly, of the DMBA-8 tumour cell clones, only the non-metastatic (NM4) cells expressed reduced levels of nm23-2 RNA relative to the parent DMBA-8 cell line (see Figure 2 for quantitation). A slightly reduced level of nm23-2 RNA (30% reduction) was observed in metastatic MAT 13762 cells relative to a clonal non-metastatic derivative, J-clone (Figures lb, 2) . The BCI cell line, derived from a spontaneous and highly aggressive rat mammary carcinoma (O'Grady et al., 1981) , also expressed the nm23-2 gene at a high level (Figures lb, 2) . Therefore, nm23-2 RNA levels did not strictly correlate with metastatic potential in cell lines derived from three independent rat mammary tumours. The 80 bp difference in size between rat nm23-1 and nm23-2 cDNAs (Shimada et al., 1993) , permitted visual distinction of the two nm23 RNA species in certain Northern blots employing less stringent washing conditions (see Materials and methods). Under such conditions, the nm23-1 gene was found to be as highly expressed as nm23-2 in metastatic MAT 13762 cells (data not shown).
The entire 600 bp nm23-2 cDNA cloned from metastatic BCI cells was sequenced (primary sequence data not shown), and despite a single base change in amino acid residue 55 (leucine; CTG to TTG), there was no alteration in the protein coding sequence when compared to rat nm23-2 (NDP kinase a) from normal tissue (see Kimura et al., 1990) . This excludes the possibility of mutational inactivation of the nm23-2/NDP kinase a protein in the metastatic BCI cells studied.
Preliminary experiments designed to study the regulation of the nm23-2 gene, revealed that nm23-2 RNA levels were not modulated by serum starvation of metastatic MAT Cytoplasmic RNA isolation and analysis Total cytoplasmic RNA was isolated by the Nonidet P-40 lysis method and analysed by Northern blotting as previously described (Henderson et al., 1992 (Henderson & Kefford, 1993) , did not down-regulate nm23 gene expression. The expression of the rat nm23-2/NDP kinase a gene and its product were previously found to be tissue-specific (Kimura et al., 1990 ). Therefore, we tested for any correlation between nm23-2 gene expression and metastasis in other rat cell-types and tumours.
nm23-2 RNA is highly expressed in rat embryo fibroblasts In contrast to nm23-1 RNA levels (Steeg et al., 1988b) The H-ras oncogene is capable of inducing the tumourigenic and metastatic phenotype in selected cell types (reviewed in Hart et al., 1989; Dear & Kefford, 1990) . Recently, transfection of a benign rat oral epithelial cell line, A5P/B10, with the EJ-H-ras oncogene, resulted in the derivation of several clonal cell lines which were metastatic in syngeneic animals (Gibbins et al., 1991) . nm23-2 RNA levels were assessed in three of these malignant H-ras transfectants (K23, K28 and K29) relative to the benign parent cell line (A5P/B10). As shown in Figure 3 , nm23-2 RNA levels were actually increased by up to 3-fold in two of the metastatic derivatives, when normalised to GAPDH signals. Similar results were observed recently for combined nm23 RNA levels in human metastatic colon cancers (Haut et al., 1991) . Three other transfected cell lines derived from A5P/B10 cell line (Y43PB, T952/F7 and F4TQ2AF) displayed a modest increase in nm23-2 RNA independent of metastatic ability (Figure 3 ). 
Discussion
The proximally-linked genes, nm23-1 and nm23-2, have been proposed to play a role in suppressing tumour metastasis in humans and rodents (see Liotta et al., 1991; Stahl et al., 1991) . The two genes disclose different tissue-specific patterns of expression in rats (Shimada et al., 1993) , suggesting that they can be independently regulated. This point is emphasised by the earlier citation of unpublished data (Stahl et al., 1991) , indicating a stronger reduction of nm23-H2 RNA levels (than nm23-H1) in v-ki-ras transfected human bronchial epithelial cells with increasing malignant behaviour. The data presented in this study, however, revealed no strict correlation between nm23-2 RNA levels and metastatic ability in cell lines derived from chemicallyinduced and spontaneous rat mammary carcinomas, or a spontaneous rat oral carcinoma. In particular, induction of metastatic competence by H-ras transfection of A5P/B1O oral carcinoma cells was not accompanied by down-regulation of the nm23-2 gene. Radinsky et al. (1992) recently undertook a detailed examination of nm23-1 RNA levels in a wide selection of clones and hybrids from the same mouse K-1735 melanoma originally described (Steeg et al., 1988a) . Whilst these investigators observed the original trend of Steeg et al. (1988a) using the clones C-19 and M-2, analysis of additional clones and somatic cell hybrids did not reveal a correlation between nm23-1 mRNA levels and metastatic potential. Moreover, in contrast to earlier data suggesting an inverse correlation between net nm23 RNA (Benilacqua et al., 1989; Hennessy et al., 1991) and protein (Barnes et al., 1991) levels in invasive human breast cancer, recent studies of nm23/NDP kinase enzyme activity and protein levels reported no correlation with lymph node metastasis in breast cancer (Lacombe et al., 1991; Sastre-Garau et al., 1992) . There are actually several examples of human tumours in which it appears that nm23 protein is more highly expressed than in normal tissue, including neuroblastoma (Hailat et al., 1991; Leone et al., 1993) , breast carcinoma, colon and cervical carcinoma (Lacombe et al., 1991) , and melanoma (Lacombe et al., 1991; Florenes 1992) . Therefore, neither nm23-1 nor nm23-2 mRNA levels appear to display a reproducible and strict MET. TUM . inverse relationship with metastatic behaviour, at least in those tumours so far studied in humans or rodents. Does this preclude involvement of the nm23/NDP kinase genes in metastasis suppression? Not necessarily. It must be borne in mind that Backer et al. (1993) recently defined very accurately the location of the human nm23-HI and nm23-H2 genes to chromosome 17q21.3, in a region known to harbour several genes such as ERBB2, HOX2, RARA and PHB, that undergo structural rearrangements and are thought to play a role in tumourigenesis (see Backer et al., 1993 for details) . In this regard, it is of interest to learn that the nm23-HI gene can undergo mutation in certain metastatic (but not nonmetastatic) colorectal adenocarcinomas (Wang et al., 1993) . In a separate investigation, Leone et al. (1993) observed a coding sequence mutation in both nm23-H1 and nm23-H2 mRNAs in sub-populations of advanced neuroblastoma. One might therefore envisage that at least in certain tumour types, mutational inactivation of nm23/NDP kinase genes may correlate and perhaps play an important role in the development of tumour metastasis. In this study, a rat nm23-2 cDNA was cloned from a single cell line (BC1) derived from a spontaneous and highly metastatic rat mammary carcinoma, and sequenced. Despite a single nucleotide change compared to normal rat NDP kinase x cDNA (Kimura et al., 1990) , there was no alteration to the amino acid coding sequence of nm23-2 mRNA in these metastatic cells. The possibility of mutational inactivation of nm23-2 mRNA in the other highly metastatic rat cell lines studied here has yet to be excluded.
Despite these correlative arguments, the only strong evidence favouring a causal role for nm23-1/NDP kinase in preventing tumour cell metastasis is based on transfection studies of metastatic K-1735 mouse melanoma cells (Leone et al., 1991) . Clearly, such gene transfection studies must be applied to other model systems, and should perhaps be performed in conjunction with antisense RNA experiments, wherein nm23-1 or nm23-2 RNA might be silenced in normal cell types prior to testing for 'induction' of metastatic competence. In view of the multiple levels of nm23 gene regulation and the absolute need to go beyond correlative studies, well-defined experiments of the type described above are likely to better address the potential involvement of nm23-1 and nm23-2 in metastasis.
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